Vaccination with IFN-inducible T cell α chemoattractant (ITAC) gene-modified tumor cell attenuates disseminated metastases of circulating tumor cells
- 1 April 2006
- Vol. 24 (15) , 2966-2974
- https://doi.org/10.1016/j.vaccine.2005.12.004
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Modification of HPV 16 E7 genes: correlation between the level of protein expression and CTL response after immunization of C57BL/6 miceVaccine, 2005
- CXC Chemokine Receptor 3 Expression by Activated CD8+ T cells Is Associated with Survival in Melanoma Patients with Stage III DiseaseCancer Research, 2004
- Intracellular Domains of CXCR3 That Mediate CXCL9, CXCL10, and CXCL11 FunctionJournal of Biological Chemistry, 2004
- Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomasJournal of Leukocyte Biology, 2004
- Activation of Tumor-specific CD4+ T Lymphocytes by Major Histocompatibility Complex Class II Tumor Cell VaccinesCancer Research, 2004
- Complementary Role of CD4+ T Cells and Secondary Lymphoid Tissues for Cross-presentation of Tumor Antigen to CD8+ T CellsThe Journal of Experimental Medicine, 2003
- Structure-Function Relationship between the Human Chemokine Receptor CXCR3 and Its LigandsJournal of Biological Chemistry, 2003
- Synergistic effect of adoptive T-cell therapy and intratumoral interferon γ-inducible protein-10 transgene expression in treatment of established tumorsCellular Immunology, 2002
- The CC Chemokine Eotaxin (CCL11) Is a Partial Agonist of CC Chemokine Receptor 2bJournal of Biological Chemistry, 2001
- Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejectionEuropean Journal of Immunology, 2001